about
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Adv...
Read More
1.38
-0.03
(-2.13%)
449.8K
XNAS Volume
XNAS 06 Mar, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Neuronetics Inc is on 17 Mar 2026 for the purpose of Neuronetics Inc Fourth Quarter Earnings Result for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks have poor scores across the board. Investors should be very cautious with these stocks
View Similar
Embed DVM
Neuronetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..